SCHEMBL4471762

SCHEMBL4471762

[C]1=Nc2ccccc2NC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12809269 0.70 GRK6 (0.31) —
SCHEMBL451291 0.67 GRK6 (0.32) —
SCHEMBL9958738 0.64 GRK6 (0.34) —
SCHEMBL330550 0.64 GRK6 (0.34) —
SCHEMBL9958734 0.64 GRK6 (0.34) —
SCHEMBL2903859 0.64 GRK6 (0.34) —
Hydrochloric Acid SCHEMBL7477355 0.62 GRK6 (0.33) —
SCHEMBL5793142 0.62 PLAU (0.31) —
Hydrochloric Acid SCHEMBL5739950 0.62 GRK6 (0.33) —
SCHEMBL29848588 0.62 MAPT (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7547693-B2 Such as N-methyl-N-(1-methylpiperidin-4-yl)-4-[4-(piperidin-1-yl)piperidin-1-yl]benzamide; histamine h3-antagonists BANYU PHARMACEUTICAL CO. LTD. (JP) 2009-06-16 — — US disclosed
US-20070105901-A1 Novel piperidine derivative MSD K.K. (JP) 2007-05-10 — — US disclosed
Send feedback